Therapeutic Advances in Musculoskeletal Disease

Papers
(The median citation count of Therapeutic Advances in Musculoskeletal Disease is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis133
Is there wastage in the research resources for ankylosing spondylitis? An analysis of clinical trial discontinuation and nonpublication outcome73
The socioeconomic status of patients with ankylosing spondylitis and its association with the burden of the disease and permanent disability: a cross-sectional cluster analysis41
Actigraphy-derived physical activity levels and circadian rhythm parameters in patients with psoriatic arthritis: relationship with disease activity, mood, age and BMI39
Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study30
Anti-sclerostin antibodies: a new frontier in fragility fractures treatment30
Big data analyses and individual health profiling in the arena of rheumatic and musculoskeletal diseases (RMDs)30
Cardio-rheumatology: integrated care and the opportunities for personalized medicine28
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data28
Similarities and differences: disentangling the intersection between axial psoriatic arthritis and axial spondyloarthritis28
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients28
Counting the costs: a nationwide study on healthcare use following an adalimumab biosimilar switch in >1300 inflammatory arthritis patients27
Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review26
Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry26
Calcineurin inhibitors in systemic sclerosis – a systematic literature review25
Health disparities in rheumatoid arthritis23
Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors22
Based on minimal clinically important difference values, a moderate dose of tanezumab may be a better option for treating hip or knee osteoarthritis: a meta-analysis of randomized controlled trials22
Reduced bone mineral density in patients with idiopathic inflammatory myopathies: a case-control study22
Wearable transcutaneous electrical nerve stimulation (actiTENS®) is effective and safe for the treatment of knee osteoarthritis pain: a randomized controlled trial versus weak opioids21
The challenge of pharmacotherapy for musculoskeletal pain: an overview of unmet needs20
A glimpse into the future of systemic lupus erythematosus20
Sjögren syndrome: looking forward to the future19
Estimation of fracture risk by the FRAX tool in patients with systemic lupus erythematosus: a 10-year longitudinal validation study19
Bone fragility: conceptual framework, therapeutic implications, and COVID-19-related issues18
Real-world evidence to assess the effectiveness of platelet-rich plasma in the treatment of knee degenerative pathology: a prospective observational study17
The association between gout flares and monosodium urate burden assessed using musculoskeletal ultrasound in patients with gout17
Stromal vascular fraction therapy for knee osteoarthritis: a systematic review17
Future challenges in rheumatology – is telemedicine the solution?17
Tofacitinib as an alternative therapy for refractory intestinal Behçet’s syndrome16
Role of imaging for eligibility and safety of a-NGF clinical trials16
Early knee OA definition–what do we know at this stage? An imaging perspective16
Gout increases length of stay in patients hospitalized for heart failure exacerbation15
Effects of acupuncture versus placebo on clinical status and potential specific effects in Fibromyalgia: an umbrella review of 11 meta-analyses15
Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care15
T-score discordance between hip and lumbar spine: risk factors and clinical implications15
Intramuscular methylprednisolone administration in hand osteoarthritis patients: a feasibility study to inform a randomized controlled trial15
Systemic lupus erythematosus is associated with increased risk of Parkinson’s disease14
Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA14
Evaluation of local tissue peri-implant reaction in total knee arthroplasty failure cases14
Development and evaluation of a multivariable prediction model for clinical improvement in an established cohort of Colombian rheumatoid arthritis patients14
Bone marrow edema in children: chronic nonbacterial osteomyelitis and its mimickers13
Mechanisms hypothesized for pain-relieving effects of exercise in fibromyalgia: a scoping review13
Magnetic resonance imaging assessments for knee segmentation and their use in combination with machine/deep learning as predictors of early osteoarthritis diagnosis and prognosis13
MRI lesions in SpA: a comparison with noninflammatory back pain using propensity score adjustment method13
Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs)13
An oleuropein-based dietary supplement may improve joint functional capacity in older people with high knee joint pain: findings from a multicentre-RCT and post hoc analysis13
Advanced imaging techniques in crystal arthritis13
A novel infrapatellar approach of ultrasound-guided intra-articular injection of the knee from both lateral and medial side: a case series13
The analysis of the pulmonary domain involvement in Sjögren’s disease12
Metabolic syndrome and psoriatic arthritis: the role of weight loss as a disease-modifying therapy12
Precision medicine using molecular-target drugs in psoriatic arthritis12
Precision medicine in axial spondyloarthritis: current opportunities and future perspectives12
Immunogenicity and safety of inactivated and mRNA COVID-19 vaccines in patients with systemic lupus erythematosus11
SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD11
Risk factors associated with the occurrence of total knee arthroplasty in patients with knee osteoarthritis: a nested case–control study11
Medication holidays in osteoporosis: evidence-based recommendations from the Italian guidelines on ‘Diagnosis, risk stratification, and continuity of care of fragility fractures’ based on a systematic11
Circulating microRNAs differentiate fast-progressing from slow-progressing and non-progressing knee osteoarthritis in the Osteoarthritis Initiative cohort11
A broad look into the future of rheumatoid arthritis11
Effects of adipose-derived mesenchymal stem cell conditioned medium on human tenocytes exposed to high glucose11
A glance into the future of myositis therapy10
Measuring sedentary behavior using waist- and thigh-worn accelerometers and inclinometers – are the results comparable?10
Muscle health in ankylosing spondylitis: effects of disease duration, inflammation, education level, and spinal mobility on skeletal muscle atrophy10
Latest insights in disease-modifying osteoarthritis drugs development10
Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumab9
Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthr9
Increased risks of aortic regurgitation and atrial fibrillation in radiographic axial spondyloarthritis patients: a 10-year nationwide cohort study9
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs)9
Osteoporosis in 10 years time: a glimpse into the future of osteoporosis8
Successful treatment of sirolimus in a Chinese patient with refractory LN and APS: a case report8
Association between bone trace elements and osteoporosis in older adults: a cross-sectional study8
Impact of obesity on clinical outcomes and treatment continuation in rheumatoid arthritis patients receiving non-TNF-targeted therapies8
Ultrasound-detected inflammation is more common in clinically manifest hand osteoarthritis than in painless bony enlarged finger joints: subanalysis of the population-based Bruneck study8
The application of machine learning in early diagnosis of osteoarthritis: a narrative review8
High inflammatory burden predicts cardiovascular events in patients with axial spondyloarthritis: a long-term follow-up study8
The burden of low back pain in children and adolescents with overweight and obesity: from pathophysiology to prevention and treatment strategies7
Meibomian gland dropout of upper eyelids as a novel biomarker for early diagnosis of primary Sjögren’s syndrome: a pilot study7
Risk of ischaemic stroke among new users of glucosamine and chondroitin sulphate: a nested case–control study7
To flare or not to flare: patients’ and rheumatologists’ perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis7
Is there still a place for methotrexate in severe psoriatic arthritis?7
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis7
Comparison of the efficacy and risk of discontinuation between non-TNF-targeted treatment and a second TNF inhibitor in patients with rheumatoid arthritis after first TNF inhibitor failure7
Tofacitinib in early active axial spondyloarthritis: protocol of a randomized double-blind, placebo-controlled, multicenter phase IV study, FASTLANE7
Bone fragility during the COVID-19 pandemic: the role of macro- and micronutrients7
Zoledronic acid does not slow spinal radiographic progression of osteoarthritis in postmenopausal women with osteoporosis and radiographic osteoarthritis7
Validation of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in ANA-positive Chinese patients7
SCORE2 is superior to SCORE in predicting the presence of carotid plaques and intima-media thickness in rheumatoid arthritis patients: a cross-sectional study using carotid ultrasound6
Orthopaedic physicians’ awareness, diagnostic challenges and referral barriers in axial spondyloarthritis: insights from a nationwide survey in Germany6
A glance into the future of gout6
The impact of psoriatic arthritis on quality of life: a systematic review6
New insights in lower limb reconstruction strategies6
Incidence rate of and risk factors for glomerulonephritis in patients with axial spondyloarthritis: a nationwide population-based study6
Association between impaired lung function and risk of spondyloarthritis: a cross-sectional study in the UK Biobank6
Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis6
Retraction notice6
Intra-articular placebo effect in the treatment of knee osteoarthritis: a survey of the current clinical evidence6
Comparison of clinical efficiency between intra-articular injection of platelet-rich plasma and hyaluronic acid for osteoarthritis: a meta-analysis of randomized controlled trials6
The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthri6
Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exp5
Uveitis in peripheral spondyloarthritis patients: an ancillary analysis of the ASAS-PerSpA study5
Effectiveness of high-frequency repetitive transcranial magnetic stimulation combined with quadriceps strength training in the treatment of knee osteoarthritis: a randomized controlled trial5
A prognostic immune nutritional index can predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis5
Neuro-PIMS-TS: a single case report and review of the literature5
Osteosarcopenia and Long-COVID: a dangerous combination5
Relationship between onset of psoriasis and spondyloarthritis symptoms with clinical phenotype and diagnosis: data from REGISPONSER registry5
RAGing ahead in rheumatology: new language model architectures to tame artificial intelligence5
A broad look into the future of systemic sclerosis5
Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes5
Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis5
Impact of csDMARDs adherence on clinical remission in patients with new-onset inflammatory arthritis: a prospective cohort study from the ELECTRA database5
Changes in ultrasound imaging of joints, entheses, bursae and tendons 24 and 48 h after adjusted weight training4
Innovations in Genicular Outcomes Registry (IGOR): protocol for a real-world registry study of treatments for knee osteoarthritis4
Concentric or eccentric physical activity for patients with symptomatic osteoarthritis of the knee: a randomized prospective study4
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study4
Effects of TNF-α inhibition versus secukinumab on active ultrasound-confirmed enthesitis in psoriatic arthritis4
A pilot study on deep learning-based grading of corners of vertebral bodies for assessment of radiographic progression in patients with ankylosing spondylitis4
Monotherapy or combination therapy in PsA: current aspects4
Cardiovascular comorbidities in psoriatic arthritis: state of the art4
Cardiovascular risk associated with allopurinol or benzbromarone treatment in patients with gout4
Clinical characteristics of myositis patients with isolated anti-U1 ribonucleoprotein antibody resemble immune-mediated necrotizing myopathy4
The role of adipose-derived mesenchymal stem cells in knee osteoarthritis: a meta-analysis of randomized controlled trials4
Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center study4
Capsular stem cell function and tissue composition are associated with symptoms and radiographic severity in people with knee osteoarthritis4
Hip replacement in femoral neck fractures: the role of cementation and its technical difficulties4
0.10740113258362